KNSA(KNSA)
KNSA
ANALYST COVERAGE11 analysts
BUY
▲ +15.6%upside to target
L $59.00
Med $62.00consensus
H $71.00PRICE
Prev Close
54.28
Open
53.69
Day Range53.16 – 55.33
53.16
55.33
52W Range25.70 – 59.87
25.70
59.87
82% of range
VOLUME & SIZE
Avg Volume
730.5K
FUNDAMENTALS
P/E Ratio
59.0x
Premium valuation
EPS (TTM)
—
Div Yield
No dividend
Beta
1.05
Market-like
TECHNICAL
RSI (14)
53
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 159 days
Oct 27
KNSA News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Megan WoodsSenior Vice President & Chief Human Resources Officer
Joseph PirrelloChief Business Officer
Mark RagosaExecutive VP & CFO
Michael R. MegnaSenior Vice President & Chief Accounting Officer
Randy PerrinGroup Vice President & Global Medical Affairs
Ross Michael MoatExecutive VP, COO & Principal Operating Officer
Sanj K. PatelChief Executive Officer & Chairman of the Board
Martina StruckSenior VP & Chief Regulatory Officer
Mei JangSenior VP & Chief Technical Officer
John F. PaoliniExecutive Vice President & Chief Medical Officer
Aaron YoungChief Intellectual Property Officer
Douglas BarrySenior Vice President, Chief Legal Officer & Secretary
Eben TessariExecutive VP & Chief Strategy Officer
Jonathan KirshenbaumInvestor Relations Officer